Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Current Investments: 2016-2024

Historic Cash & Current Investments for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $136.2 million.

  • Organogenesis Holdings' Cash & Current Investments fell 28.25% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.6 million, marking a year-over-year increase of 5.42%. This contributed to the annual value of $136.2 million for FY2024, which is 30.49% up from last year.
  • Organogenesis Holdings' Cash & Current Investments amounted to $136.2 million in FY2024, which was up 30.49% from $104.3 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Cash & Current Investments ranged from a high of $136.2 million in FY2024 and a low of $84.8 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Cash & Current Investments had a median value of $104.3 million in 2023 and averaged $114.6 million.
  • In the last 5 years, Organogenesis Holdings' Cash & Current Investments skyrocketed by 43,168.37% in 2020 and then dropped by 9.81% in 2022.
  • Organogenesis Holdings' Cash & Current Investments (Yearly) stood at $84.8 million in 2020, then surged by 35.05% to $114.5 million in 2021, then dropped by 9.81% to $103.3 million in 2022, then rose by 1.01% to $104.3 million in 2023, then soared by 30.49% to $136.2 million in 2024.